Sign In
Buy ACAD
$22.60
+0.510 (+2.31%)
At Close: Jun 23, 2026
Birchview Capital, LP Buys ACADIA Pharmaceuticals Inc, Biogen Inc, Neurocrine Biosciences Inc, ...
12:00am, Tuesday, 12'th May 2020Analysts Have Made A Financial Statement On ACADIA Pharmaceuticals Inc.'s (NASDAQ:ACAD) First-Quarter Report
12:02pm, Saturday, 09'th May 2020
It's been a pretty great week for ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) shareholders, with its shares surging 13...
Acadia Pharmaceuticals (ACAD) Q1 2020 Earnings Call Transcript
02:31am, Saturday, 09'th May 2020
ACAD earnings call for the period ending March 31, 2020.
Edited Transcript of ACAD earnings conference call or presentation 7-May-20 8:30pm GMT
08:27pm, Friday, 08'th May 2020
Q1 2020 ACADIA Pharmaceuticals Inc Earnings Call
JP Morgan Maintains Overweight on ACADIA Pharmaceuticals, Raises Price Target to $55
04:00pm, Friday, 08'th May 2020ACADIA's (ACAD) Q1 Earnings & Revenues Fall Shy of Estimates
02:55pm, Friday, 08'th May 2020
ACADIA's (ACAD) earnings and sales lag estimates in the first quarter of 2020. The company trims its 2020 revenue guidance due to the coronavirus impact. Stock declines in after-hours trading.
Cantor Fitzgerald Reiterates Overweight on ACADIA Pharmaceuticals, Raises Price Target to $63
11:05am, Friday, 08'th May 2020ACADIA Pharmaceuticals Inc. (ACAD) CEO Steve Davis on Q1 2020 Results - Earnings Call Transcript
03:38am, Friday, 08'th May 2020
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q1 2020 Earnings Conference Call May 7, 2020 4:30 PM ET Company Participants Mark Johnson - Vice President of Investor
ACADIA's (ACAD) Q1 Earnings & Revenues Fall Shy of Estimates
12:00am, Friday, 08'th May 2020Acadia Pharmaceuticals (ACAD) Reports Q1 Loss, Lags Revenue Estimates
10:10pm, Thursday, 07'th May 2020
Acadia (ACAD) delivered earnings and revenue surprises of -23.91% and -3.36%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
ACADIA Pharmaceuticals Reports First Quarter 2020 Financial Results
08:06pm, Thursday, 07'th May 2020
ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs in central nervous syste
ACADIA Pharmaceuticals and Vanderbilt University Announce Exclusive License Agreement and Research Collaboration
08:05pm, Thursday, 07'th May 2020
ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD) and Vanderbilt University today announced an exclusive worldwide license agreement to develop and commercialize novel drug candidates targeting the muscarini
The Daily Biotech Pulse: FDA Approves Novartis Lung Cancer Drug, 2-Way Contest Emerging For Tetraphase Pharma, Dexcom To Join S&P 500
12:00am, Thursday, 07'th May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks hitting 52-week highs May 6.)
Adverum Biotechnologies Inc...
